[EN] N-ADAMANT-1-YL-N'-[4-CHLOROBENZOTHIAZOL-2-YL] UREA USEFUL IN THE TREATMENT OF INFLAMMATION AND AS AN ANTICANCER RADIOSENSITIZING AGENT<br/>[FR] N-ADAMANT-1-YL-N'-[4-CHLOROBENZOTHIAZOL-2-YL] UREE UTILISEE DANS LE TRAITEMENT DES INFLAMMATIONS ET COMME AGENT DE RADIOSENSIBILISATION ANTICANCEREUX
申请人:DU PONT PHARM CO
公开号:WO2000056725A1
公开(公告)日:2000-09-28
This invention relates generally to N-adamant-1-yl-N'-[4-chlorobenzolthiazol-2-yl] urea, pharmaceutical compositions comprising the same, and methods of using the same in the treatment of inflammation and as an anticancer radiosensitizing agent.